Nauzene Chewables
Natural health product licensed in Canada
- Licence holder
- Kobayashi Healthcare International, Inc.
- NPN or DIN-HM
- 80040702
- Status
- Active licence
- Licence date
- 11 March 2013
- Revision date
- Not provided
- Form
- Comprimé, à croquer
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| D-Fructose Source : High fructose corn syrup | 175 mg | Not calculated |
| D-glucose Source : High fructose corn syrup | 968 mg | Not calculated |
| D-glucose Source : Zea mays - fruit | 968 mg | Not calculated |
| Citrate de trisodium dihydraté Source : Sodium citrate dihydrate | 230 mg | Not calculated |
Non-medicinal ingredients
Acide stéarique, Stéarate de magnésium, Maltodextrine, Saveur de cerise, Aspartame, Dioxyde de silicium colloïdal, Laque d'aluminiium FD&C rouge n° 40
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 2 Comprimé ; maximum: 4 Comprimé | minimum: 1 day ; maximum: 6 days |
Uses authorised in Canada
For the relief of hearburn, acid indigestion, upset stomach and nausea associated with overindulgence in food and drink.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Stop use and ask a doctor if nausea lasts more than two weeks or recurs frequently. Read all package directions and warnings before use and use only as directed. Nauzene Chewables are intended for use by normally healthy persons only. Persons under 18 years of age should use only as directed by a doctor. Not recommended for use by women who are pregnant or breastfeeding. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
- Contre-indications
Do not use if you have Hereditary Fructose Intolerance (HFI) because this product contains fructose. Ask a doctor before use if you have diabetes because this product contains sugar; are on a sodium restricted diet as each chewable tablet contains 54 mg sodium; or have phenylketonuria because each chewable tablet contains 4.5 mg phenylalanine. Ask a doctor or pharmacist before use if you are taking any other medications. Antacids may interact with certain prescription drugs.
Source
Official Health Canada record, licence 80040702
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.